Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

19 Mar 2021

Abstract excerpt

The survival rate in lung cancer remains stubbornly low and there is an urgent need for the identification of new therapeutic targets. In the last decade, several members of the SWI/SNF chromatin remodeling complexes have been described altered in different tumor types. Nevertheless, the precise mechanisms of their impact on cancer progression, as well as the application of this knowledge to cancer patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Chromatin Remodeling and Cancer
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33742126
DOI: 10.1038/s41388-021-01748-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerPMID 33742126Read ↗

<i>ARID2</i> deficiency promotes tumor progression and is associated with higher sensitivity to PARP inhibition in lung cancerSemantic proximity Read ↗

Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.Semantic proximity Read ↗

ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications.Semantic proximity Read ↗

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS- STING Pathway in Non-Small Cell Lung CancerSemantic proximity Read ↗

Targeting HSPA1A in ARID2-deficient lung adenocarcinomaSemantic proximity Read ↗

ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung CancerSemantic proximity Read ↗

ARID1A mutations in cancer: another epigenetic tumor suppressor?Semantic proximity Read ↗

ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR.Semantic proximity Read ↗

ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosisSemantic proximity Read ↗

ARID1A loss in cancer: Towards a mechanistic understanding.Semantic proximity Read ↗

Role of SWI/SNF chromatin remodeling genes in lung cancer developmentSemantic proximity Read ↗

Targeting ARID1A mutations in cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.